Severe Multi-Resistant Pemphigus vulgaris: prolonged remission with a single cycle of Rituximab

• Egile Nagusiak: Isabela Soubhia Corral (Egilea), Thais Helena Proença de Freitas (Egilea), Renata Telles Rudge de Aquino (Egilea), Daniella Abbruzzini S. Koller (Egilea), Maria Elisa Ruffolo Magliari (Egilea), Helena Muller (Egilea)
• Formatua: Liburua
• Argitaratua: Sociedade Brasileira de Dermatologia, 2013-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Pemphigus vulgaris is an autoimmune bullous disease whose therapy is based on systemic corticosteroids, with or without immunosuppressants. Rituximab is a chimeric monoclonal antibody of the IgG class, directed at a specific CD20 B cell surface antigen, used in pemphigus vulgaris empirically since 2...